By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Italian drug screening technologies company Axxam will collaborate with Swiss firm Polyphor on ion channel-based research, the firms said today.

The partners will use their respective drug discovery and screening platforms to identify drug candidates for therapeutic areas including pain, inflammation, and metabolic disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.